登录 注册 会员服务 联系我们

Expanding the long-axial field-of-view PET-CT horizons: unveiling new arrows in our quiver

  • Published:2024-03-04 Issue:7 Volume:51 Page:2098-2099
  • ISSN:1619-7070
  • Container-title:European Journal of Nuclear Medicine and Molecular Imaging
  • language:en
  • Short-container-title:Eur J Nucl Med Mol Imaging

Author:

Ponsiglione Andrea,Nappi Carmela,Volpe Fabio,Klain Michele

Publisher

Springer Science and Business Media LLC

Reference11 articles.

1. Kokabi N, Webster LA, Elsayed M, Switchenko JM, Chen B, Brandon D, et al. Accuracy and safety of scout dose resin Yttrium-90 microspheres for radioembolization therapy treatment planning: a prospective single-arm clinical trial. J Vasc Interv Radiol. 2022;33:1578-1587.e5. https://doi.org/10.1016/j.jvir.2022.08.027.

2. Vilgrain V, Pereira H, Assenat E, Guiu B, Ilonca AD, Pageaux G-P, et al. Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial. Lancet Oncol. 2017;18:1624–36. https://doi.org/10.1016/S1470-2045(17)30683-6.

3. Imbriaco M, De Luca S, Coppola M, Fusari M, Klain M, Puglia M, et al. Diagnostic Accuracy of Gd-EOB-DTPA for Detection Hepatocellular Carcinoma (HCC): A comparative study with dynamic contrast enhanced magnetic resonance imaging (MRI) and dynamic contrast enhanced computed tomography (CT). Pol J Radiol. 2017;82:50–7. https://doi.org/10.12659/PJR.899239

4. Edeline J, Touchefeu Y, Guiu B, Farge O, Tougeron D, Baumgaertner I, et al. Radioembolization plus chemotherapy for first-line treatment of locally advanced intrahepatic cholangiocarcinoma: a phase 2 clinical trial. JAMA Oncol. 2020;6:51–9. https://doi.org/10.1001/jamaoncol.2019.3702.

5. Dhondt E, Lambert B, Hermie L, Huyck L, Vanlangenhove P, Geerts A, et al. 90Y Radioembolization versus drug-eluting bead chemoembolization for unresectable hepatocellular carcinoma: results from the TRACE phase II randomized controlled trial. Radiology. 2022;303:699–710. https://doi.org/10.1148/radiol.211806.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Artificial intelligence-based application in multiple myeloma;European Journal of Nuclear Medicine and Molecular Imaging;2024-04-08
同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3